Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 7 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

14%

1 trials in Phase 3/4

Results Transparency

0 of 4 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

Phase 2

1(33.3%)

Phase 3

1(33.3%)

N/A

1(33.3%)

3Total

Phase 2(1)

Phase 3(1)

N/A(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (7)

Showing 7 of 7 trials

NCT07294586Completed

Exploratory Clinical Study and Validation of Blood Biomarkers for Alzheimer's Disease

Role: collaborator

NCT05040464Phase 3Recruiting

Comparison of Azathioprine to Methotrexate in Combination Therapy With Adalimumab in Crohn's Disease: an Open-label Randomized Controlled Trial

Role: collaborator

NCT03030586Completed

ADDIA Proof-of-Performance Clinical Study

Role: collaborator

NCT06355544Not Yet Recruiting

Individual Factors Related to Chronic Low-grade Inflammation and Cardiometabolic Disease Risk

Role: collaborator

NCT04937582Not ApplicableCompleted

Cognitive and Psychological Disorders After Severe COVID-19 Infection

Role: collaborator

NCT04671290Completed

Temocillin Versus Carbapenems for Urinary Tract Infection Due to ESBL-producing Enterobacteriaceae

Role: collaborator

NCT01857453Phase 2Unknown

Interest of a Dose Decrease for Radiotherapy Associated With Chemotherapy for Treatment of Standard Risk Adult Medulloblastomas

Role: collaborator

All 7 trials loaded